Last updated: 11 September 2024 at 4:57pm EST

David Hoffmeister Net Worth




The estimated Net Worth of David F Hoffmeister is at least 5.78 百万$ dollars as of 30 May 2024. Mr. Hoffmeister owns over 22,500 units of Celanese Corp stock worth over 5,525,287$ and over the last 19 years he sold CE stock worth over 0$. In addition, he makes 254,961$ as Independent Director at Celanese Corp.

Mr. Hoffmeister CE stock SEC Form 4 insiders trading

David has made over 21 trades of the Celanese Corp stock since 2008, according to the Form 4 filled with the SEC. Most recently he bought 22,500 units of CE stock worth 996,525$ on 30 May 2024.

The largest trade he's ever made was exercising 192,728 units of Celanese Corp stock on 14 September 2009 worth over 5,300,020$. On average, David trades about 4,596 units every 71 days since 2006. As of 30 May 2024 he still owns at least 45,853 units of Celanese Corp stock.

You can see the complete history of Mr. Hoffmeister stock trades at the bottom of the page.





David Hoffmeister biography

David F. Hoffmeister is an Independent Director of the Company. Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by Fisher Scientific Inc. in February 2014. From October 2004 to November 2008, he served as Chief Financial Officer of Invitrogen Corporation, which merged with Applied Biosystems in November 2008 to form Life Technologies Corporation. Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey & Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of strategy and organization. From 1998 to 2003, Mr. Hoffmeister was the leader of McKinsey’s North American chemical practice. Mr. Hoffmeister serves as a director of Glaukos Corporation (since 2014) and member of the audit committee. He also serves as a director (since 2018) of ICU Medical Inc. and is a member of its audit committee and compensation committee.

What is the salary of David Hoffmeister?

As the Independent Director of Celanese Corp, the total compensation of David Hoffmeister at Celanese Corp is 254,961$. There are 13 executives at Celanese Corp getting paid more, with Lori Ryerkerk having the highest compensation of 6,027,800$.



How old is David Hoffmeister?

David Hoffmeister is 65, he's been the Independent Director of Celanese Corp since 2016. There are 3 older and 13 younger executives at Celanese Corp. The oldest executive at Celanese Corp is John Wulff, 71, who is the Independent Director.

What's David Hoffmeister's mailing address?

David's mailing address filed with the SEC is C/O STEPSTONE GROUP INC., 277 PARK AVENUE, 45TH FLOOR, NEW YORK, NY, 10172.

Insiders trading at Celanese Corp

Over the last 20 years, insiders at Celanese Corp have traded over 40,778,149$ worth of Celanese Corp stock and bought 16,005 units worth 1,386,578$ . The most active insiders traders include William M BrownJames E BarlettScott Mc Dougald Sutton. On average, Celanese Corp executives and independent directors trade stock every 69 days with the average trade being worth of 2,403,252$. The most recent stock trade was executed by Scott A Richardson on 19 August 2024, trading 9,350 units of CE stock currently worth 1,210,451$.



What does Celanese Corp do?

who is celanese? we’re engineers, scientists, operators and product developers. we’re innovators, advisers, designers and problem solvers. most importantly, we’re partners – in creating value for our customers with the solutions we offer and in improving the world through the actions of our colleagues. celanese is the chemistry inside innovation™ and we aspire to be the first-choice chemistry solution source for our customers. we know what you’re thinking – that’s a lot to promise and that’s a lot to do. well, we would agree with you, but we’re up for the challenge and we owe it to our customers, shareholders, and employees to deliver on our promise. what does celanese do? we produce products that make our lives a little easier, by helping customers to bring their inspired ideas and innovations to life. from the global production network of our acetyl chain, we provide materials that are critical to the global chemicals and paints and coatings industries. from our broad portfol



Complete history of Mr. Hoffmeister stock trades at Atyr Pharma Inc、ICU Medical、Celanese Corp、Glaukos、StepStone

インサイダー
取引
取引
合計金額
David F Hoffmeister
ディレクター
購入する 996,525$
30 May 2024
David F Hoffmeister
オプション行使 99,047$
15 May 2024
David F Hoffmeister
オプション行使 92,160$
17 May 2023
David F Hoffmeister
オプション行使 75,121$
11 May 2022
David F Hoffmeister
オプション行使 91,995$
11 May 2021
David F Hoffmeister
オプション行使 68,792$
13 May 2020
David F Hoffmeister
オプション行使 70,960$
15 May 2019
David F Hoffmeister
オプション行使 72,800$
10 Apr 2024
David F Hoffmeister
ディレクター
オプション行使 525,500$
16 Mar 2016
David F Hoffmeister
最高財務責任者
オプション行使 942,030$
1 Apr 2013
David F Hoffmeister
最高財務責任者
オプション行使 1,167,401$
1 Mar 2013
David F Hoffmeister
最高財務責任者
オプション行使 458,923$
2 Apr 2012
David F Hoffmeister
最高財務責任者
オプション行使 1,527,087$
21 Nov 2011
David F Hoffmeister
最高財務責任者
オプション行使 177,984$
16 May 2011
David F Hoffmeister
最高財務責任者
オプション行使 271,731$
17 May 2010
David F Hoffmeister
最高財務責任者
オプション行使 97,228$
15 Mar 2010
David F Hoffmeister
最高財務責任者
オプション行使 200,720$
1 Mar 2010
David F Hoffmeister
最高財務責任者
オプション行使 5,300,020$
14 Sep 2009
David F Hoffmeister
最高財務責任者
オプション行使 0$
12 May 2009
David F Hoffmeister
最高財務責任者
オプション行使 0$
14 Mar 2009
David F Hoffmeister
最高財務責任者
オプション行使 0$
30 Nov 2008


Celanese Corp executives and stock owners

Celanese Corp executives and other stock owners filed with the SEC include: